"Flow Cytometry Bioanalysis - Rising of the 3rd Most Common/Important Technology in Bioanalytical Labs"
Importance of learning Flow, Mass, Imagine & Spectral Cytometry Bioanalysis and Major Applications in Biomarkers, Immunogenicity, Cell Therapy, Vaccine, Omics and Non-Liquid Matrices; Novel Techniques, Autogating Developments and Innovation in High Dimensional Cytometry - Social Networking Reception and Dinner is also Included - Flow Cytometry Day and Night!
Part 1: Understanding the Cytometry Conventional/Novel Technologies and Main Applications
Importance of Conventional Flow Cytometry Bioanalysis for Clinical Trials – Past, Present, Future: Technology Introduction & Main Applications in Immunophenotyping, RO and PD Assays
Importance of Spectral Cytometry for Biomarker Development – Current Status and Future Developments: Technology Introduction & Primary Unique Features vs Conventional Flow Cytometry, Main Application in Drug Discovery & Development
Importance of Mass Cytometry for Bioanalytical Needs – Past, Present, Future: Technology Introduction, Primary Unique Features vs Conventional Flow Cytometry & Applications in Bioanalysis & Biomeasures
Importance of Imaging Cytometry for Biomeasures – Past, Present, Future: Technology Introduction & Applications in Cell-based Biomeasure Assays
Part 2: Current Challenges with Validation & Sample Collection
Strategies for Rationalizing Fit-for-purpose Criteria for Flow Cytometry Biomarker Assay Validation (BAV): How to Determine what Parameters/Acceptance Criteria are really needed without overdoing or underdoing?
Turning the CLSI H62 into Practise for Bioanalytical/Clinical Laboratories: First-hand experience in trying to apply the CLSI H62 to real situations with pros & cons
Challenges and Strategies for Clinical Sample Collection in Flow Cytometry and Cell-Based Assays
Part 3: Specific Complex Applications
Flow Cytometry in the Monitoring of Immune Responses to Vaccines: Method Development challenges and Assay Optimization Strategies to Increases the Robustness and Accuracy of the Data
Use of Model Antigens to Validate Antigen Specific Vaccine Flow Cytometry Assays
Challenges and Value of Clinical Receptor Occupancy (RO) Assessments for Bispecific T Cell redirection by Flow Cytometry
Challenges in the Development of Novel Flow Cytometry Assays for Bioanalysis of PD Markers: RO of Small Molecule inhibitor, Tumor Tissue and Phagocytosis Measurements
Part 4: Innovation in Cytometry
Can we use Cytometry in Tissues Bioanalysis? Current Challenges, Innovative Approaches and Technologies
Recent Advancements in Fit-for-purpose Validation Requirements for High Parameter Cytometry Assays with/without Autogating
Current Evolution of High Dimensional Flow Cytometry Data in Clinical Settings and needs for Autogating
Part 5: White Paper in Bioanalysis
2022 White Paper on Cytometry Topics:
Consensus & Conclusions on Cytometry Topics for 2022 White Paper